QuickView for Tace;jsessionid=2B370222F07357542C739905C1140B15;jsessionid=B81DFB16B2FC50DC8B5811BE2DE3BDC0;jsessionid=26198012C24E18CA46F00FF91A651E52;jsessionid=4C1F0E16C60344DE05ECDFB3039E82A2;jsessionid=C8524875D0EB670B2A0B5CD56F69498D;jsessionid=546F4601A30875ED75325DFDEB2B9F8E;jsessionid=89C4DA8B7CFE56C78BEC26060152C90B (gene)

1. The metalloprotease ADM-4/ADAM17 promotes axonal repair.
2. The protease ADAM17 at the crossroads of disease: revisiting its significance in inflammation, cance…
3. ADAM17: A novel treatment target for aneurysms.
4. Phylogeny and expression of ADAM10 and ADAM17 homologs in lamprey.
5. Inhibitory monoclonal antibody targeting ADAM17 expressed on cancer cells.

There were no clinical trials for Tace;jsessionid=2B370222F07357542C739905C1140B15;jsessionid=B81DFB16B2FC50DC8B5811BE2DE3BDC0;jsessionid=26198012C24E18CA46F00FF91A651E52;jsessionid=4C1F0E16C60344DE05ECDFB3039E82A2;jsessionid=C8524875D0EB670B2A0B5CD56F69498D;jsessionid=546F4601A30875ED75325DFDEB2B9F8E;jsessionid=89C4DA8B7CFE56C78BEC26060152C90B